Addressing The Data Integrity Challenge

A UK-based pharmaceutical company with over 300 employees across multiple European locations, expanded through mergers and acquisitions, involved in formulation, analytical development, QC testing, process and device development, and pilot manufacture. At the time, the company relied on paper and Excel-based processes, had many non-networked instruments, and spent over 30% of scientists' and team leaders' time on manual data checking. The mergers led to inconsistent ways of working.

After being brought on board, ProPharma conducted stakeholder interviews to understand the current situation and its business implications, identified and prioritized data integrity gaps and risks, and provided clear, actionable recommendations for process harmonization. They developed a quantifiable ROI to support a robust business case, documented focused User Requirements Specification (URS) and RFI/RFP, and supported vendor selection. ProPharma also offered project oversight and expertise during deployment and validation.

Learn more about how ProPharma was able to help the pharmaceutical company by downloading the case study below.